Tissue Diagnostics Market is Expected to Reach $8.4 Billion | MarketsandMarkets™

Chicago, Jan. 29, 2024 (GLOBE NEWSWIRE) — Tissue Diagnostics market in terms of revenue was estimated to be worth $5.6 Billion in 2023 and is poised to reach $8.4 Billion by 2028, growing at a CAGR of 8.4% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. The tissue diagnostics market is driven by growing healthcare expenditure, developing infrastructure for cancer diagnosis, and increasing technological advancements in tissue diagnostics.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1063949

Tissue Diagnostics Market Scope:

Report Coverage Details
Market Revenue in 2023 $5.6 Billion
Estimated Value by 2028 $8.4 Billion
Growth Rate Poised to grow at a CAGR of 8.4%
Market Size Available for 2021 – 2028
Forecast Period 2023 – 2028
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Product, Technology, Disease Type, End User, and Region
Geographies Covered North America (US, Canada), Europe (Germany, France, UK, Spain, Italy, and RoE), APAC (China, India, Japan, and the RoAPAC), and Rest of the World (Latin America, and Middle East & Africa)
Report Highlights Updated financial information / product portfolio of players
Key Market Opportunity Significant opportunities in BRICS Countries
Key Market Driver Growing demand for digital pathology

Healthcare expenditure constitutes a significant part of the development budget of all the countries. It consists of spending by both public and private sources on medical goods and services.

Based on products, the tissue diagnostics market is segmented into Consumables (Antibodies, Kits, Reagents, and Probes) and Instruments (Slide-staining Systems, Scanners, Tissue-processing Systems, and Other Instruments). The consumables segment is forecasted to drive the market. The rise in government and private funding in life sciences and cancer research, growing R&D expenditure by leading pharma companies, the increasing number of reagent rental agreements and the application of innovative technologies & methodologies in the fields of tissue diagnostics and in vitro diagnostics are factors expected to drive the growth of the tissue diagnostics consumables market during the forecast period.

Based on technology, the tissue diagnostics market is segmented into global tissue diagnostics market is segmented into Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Management, and Special Staining. Immunohistochemistry segment accounted for the largest share of the tissue diagnostics market in 2022. The rising preference for the use of IHC tests for diagnosing conditions such as cancer is driving the segment’s growth.

Based on disease type, the tissue diagnostics market is segmented into Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, and Other Disease Types. In 2022, breast cancer accounted for the largest share of the tissue diagnostics market. This segment is also projected to register the highest CAGR during the forecast period, owing to the rise in the number of Breast cancer cases and, Other lifestyle changes that lead to breast cancer.

Based on end user, the tissue diagnostics market is segmented into Hospitals, Pharmaceutical Companies, Research Laboratories, Contract Research Organizations, and Other End Users. Hospitals accounted for largest share of the tissue diagnostics market in 2022. The significant share of the segment is primarily due to the increasing number of patients visiting hospitals, the rising number of in-house diagnostics procedures performed in hospitals, and growing awareness regarding early diagnosis of cancer.

Based on the region, The tissue diagnostics market is segmented into North America, Europe, the Asia Pacific, and Rest of the World (RoW). The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The presence of target population in emerging economies such as China, India, and Japan, the rising prevalence of chronic diseases, and increasing healthcare spending are expected to boost the market growth in the Asia Pacific region.

Buy a Tissue Diagnostics Industry Report (240 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=1063949

Tissue Diagnostics market major players covered in the report, such as:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Danaher Corporation (US)
  • PHC Holdings Corporation Corporation (Japan)
  • Thermo Fisher Scientific, Inc (US)
  • Abbott (US)
  • Agilent Technologies Inc. (US)
  • Merck KGAA (Germany)
  • Abcam Plc. (UK)
  • Becton, Dickinson and Company (BD) (US)
  • Bio SB (US)
  • Biogenix (US)
  • Cell Signaling Technology, Inc (US)
  • Histo-Line Laboratories (Italy)
  • SLEE Medical GMBH (Germany)
  • Cellpath Ltd (UK)
  • Amos scientific Pty Ltd. (Australia)
  • Jinhua YIDI Medical Appliance CO., LTD (China)
  • MEDITE Medical GmbH (Germany)
  • Diapath S.p.A. (Italy)
  • Diagnostic BioSystems Inc. (US)
  • 3DHISTECH (Hungary)
  • RWD Life Science Co., LTD (China)
  • Dakewei Biotechnology co., Ltd (China)
  • Sysmax Corporation (Japan)
  • Enzo Life Sciences, Inc. (US)
  • Biocare Medical, LLC. (US)
  • Bio-Optica Milano Spa (Italy)
  • and Among Others

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1063949

This report categorizes the tissue diagnostics market into the following segments and subsegments:

By Product

  • Consumables
    • Antibodies
    • Kits
    • Reagents
    • Probes
  • Instruments
    • Slide-staining Systems
    • Scanners
    • Tissue-processing Systems
    • Other Instruments (automated cover slippers, microtomes, embedding systems, paraffin dispensers, and slide labelers)

By Technology

  • Immunohistochemistry
  • In Situ Hybridization
  • Digital Pathology & Workflow Management
  • Special Staining

By Disease Type

  • Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-small Cell Lung Cancer
  • Other Disease Types (neurological disease, cardiovascular disease, immunological diseases, infectious diseases, cancers of the bone, colon, thyroid, cervix, and skin; gallbladder carcinoma; HBV; Epstein-Barr virus; hepatitis; muscular dystrophy; renal cell carcinoma; and pleomorphic sarcomas.)

By End User

  • Hospitals
  • Research Laboratories
  • Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Other End Users (reference laboratories and academic research laboratories)

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Rest of The World (RoW)
    • Latin America
    • Middle East & Africa

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=1063949

Key Market Stakeholders:

  • Senior Management
  • End User
  • Finance/Procurement Department
  • R&D Department

Report Objectives:

  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To define, describe, segment, and forecast the tissue diagnostics market by product, technology, disease type, and end user, and region
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall tissue diagnostics market
  • To forecast the size of the tissue diagnostics market in four main regions along with their respective key countries, namely, North America, Europe, Asia Pacific, and Rest of the World.
  • To profile key players in the tissue diagnostics market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as product launches and approvals; expansions; and partnerships; of the leading players in the tissue diagnostics market
  • To benchmark players within the tissue diagnostics market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Related Reports:

Molecular Diagnostics Market

Immunohistochemistry (IHC) Market

In Vitro Diagnostics Market

Slide Stainer Market

In Situ Hybridization Market

Research Insights: https://www.marketsandmarkets.com/ResearchInsight/tissue-diagnostics-market.asp

Content Source: https://www.marketsandmarkets.com/PressReleases/tissue-diagnostics.asp

CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. SingaporeOutlook.com takes no editorial responsibility for the same.